US FDA grants accelerated approval to Etcamah for ESR1-mutant breast cancer
US FDA granted accelerated approval to Etcamah for advanced breast cancer with an ESR1 mutation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.